Vittal Kurisetty

454 total citations
10 papers, 390 citations indexed

About

Vittal Kurisetty is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Vittal Kurisetty has authored 10 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Rheumatology. Recurrent topics in Vittal Kurisetty's work include Cancer-related Molecular Pathways (3 papers), Bone and Dental Protein Studies (3 papers) and dental development and anomalies (3 papers). Vittal Kurisetty is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Bone and Dental Protein Studies (3 papers) and dental development and anomalies (3 papers). Vittal Kurisetty collaborates with scholars based in United States, United Kingdom and Australia. Vittal Kurisetty's co-authors include Philip S. Rudland, Mohamed El‐Tanani, F C Campbell, Maureen C. McCann, Rajkumar Lakshmanaswamy, Chendil Damodaran, Trinath P. Das, Suman Suman, Patrick G. Johnston and Brad A. Bryan and has published in prestigious journals such as Oncogene, Cytokine & Growth Factor Reviews and BMC Cancer.

In The Last Decade

Vittal Kurisetty

10 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vittal Kurisetty United States	9	237	109	107	78	56	10	390
Marco A. Briones‐Orta Mexico	12	237 1.0×	67 0.6×	78 0.7×	58 0.7×	31 0.6×	17	410
Swapnil Karnik India	7	144 0.6×	81 0.7×	90 0.8×	81 1.0×	29 0.5×	16	333
Masayoshi Namba Japan	8	249 1.1×	65 0.6×	76 0.7×	54 0.7×	40 0.7×	11	393
Huilin Jin China	15	276 1.2×	45 0.4×	100 0.9×	140 1.8×	38 0.7×	26	508
Petar Ozretić Croatia	17	497 2.1×	28 0.3×	182 1.7×	127 1.6×	113 2.0×	52	664
Geetpriya Kaur India	6	157 0.7×	29 0.3×	136 1.3×	173 2.2×	15 0.3×	13	410
Ju Ma China	13	297 1.3×	41 0.4×	101 0.9×	189 2.4×	29 0.5×	19	487
Bettina Grötsch Germany	9	200 0.8×	59 0.5×	102 1.0×	93 1.2×	38 0.7×	12	478
Hidenori Miyamoto Japan	11	209 0.9×	40 0.4×	296 2.8×	66 0.8×	17 0.3×	24	554

Countries citing papers authored by Vittal Kurisetty

Since Specialization

Citations

This map shows the geographic impact of Vittal Kurisetty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vittal Kurisetty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vittal Kurisetty more than expected).

Fields of papers citing papers by Vittal Kurisetty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vittal Kurisetty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vittal Kurisetty. The network helps show where Vittal Kurisetty may publish in the future.

Co-authorship network of co-authors of Vittal Kurisetty

This figure shows the co-authorship network connecting the top 25 collaborators of Vittal Kurisetty. A scholar is included among the top collaborators of Vittal Kurisetty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vittal Kurisetty. Vittal Kurisetty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Kurisetty, Vittal. (2014). Pathogenic and therapeutic role of miRNAs in breast cancer. Frontiers in bioscience. 19(1). 1–1. 9 indexed citations

Amaya, Clarissa, Vittal Kurisetty, Alice M. Nyakeriga, et al.. (2014). A genomics approach to identify susceptibilities of breast cancer cells to “fever-range” hyperthermia. BMC Cancer. 14(1). 81–81. 15 indexed citations

Kurisetty, Vittal, et al.. (2014). Rho kinase proteins regulate global miRNA expression in endothelial cells.. PubMed. 10(6). 251–63. 26 indexed citations

Suman, Suman, et al.. (2013). Activation of AKT signaling promotes epithelial–mesenchymal transition and tumor growth in colorectal cancer cells. Molecular Carcinogenesis. 53(S1). E151–60. 80 indexed citations

Kurisetty, Vittal. (2013). Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma. PubMed. 1(1). 8 indexed citations

Kurisetty, Vittal, Rae Myers, Jarrard Goodwin, et al.. (2013). Preclinical safety and activity of recombinant VSV‐IFN‐β in an immunocompetent model of squamous cell carcinoma of the head and neck. Head & Neck. 36(11). 1619–1627. 21 indexed citations

Kurisetty, Vittal, et al.. (2012). Role of Plasminogen Activator Inhibitor-1 in Urokinase's Paradoxical In Vivo Tumor Suppressing or Promoting Effects. Molecular Cancer Research. 10(10). 1271–1281. 14 indexed citations

Kurisetty, Vittal, Patrick G. Johnston, Philip S. Rudland, & Mohamed El‐Tanani. (2009). Identification of genes differentially expressed between benign and osteopontin transformed rat mammary epithelial cells. BMC Research Notes. 2(1). 15–15. 4 indexed citations

Kurisetty, Vittal, Patrick G. Johnston, Nicholas Johnston, et al.. (2008). RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin. Oncogene. 27(57). 7139–7149. 69 indexed citations

10.

El‐Tanani, Mohamed, et al.. (2006). The regulation and role of osteopontin in malignant transformation and cancer. Cytokine & Growth Factor Reviews. 17(6). 463–474. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact